4th Annual High Potent Medicines Conference (Rome, Italy - May 28-29, 2020): Latest Industry Trends, Advancements & Future Growth, Industry Expert Strategies for Both Pharma & CMO'sHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)4th Annual High Potent Medicines Conference (Rome, Italy - May 28-29, 2020): Latest Industry Trends, Advancements & Future Growth, Industry Expert Strategies for Both Pharma & CMO'sGlobeNewswireJanuary 8, 2020ReblogShareTweetShareDublin, Jan. 08, 2020 (GLOBE NEWSWIRE) -- The "4th Annual High Potent Medicines Conference" conference has been added to ResearchAndMarkets.com's offering.The 2-day event will share the latest industry trends, advancements and future growth in the highly potent medicines market where leading industry experts will discuss the strategies for both pharma and CMO's.Expert keynote presentations, live case studies, and breakthrough panel sessions on solutions to the challenges with regards to cleaning and validation in API Manufacturing and procedures to avoid cross-contamination.The cytotoxic nature of HPAPIs presents significant handling challenges and thus requires heavy investments for implementing specialized containment facilities that facilitate the safety of employees from exposure. Owing to their target release characteristics, HPAPIs find major applications in target therapies for cancer.One of the major challenges faced by the players in this market, especially CMOs that offer HPAPI manufacturing services, is the continual evolution of industry standards, technologies, and regulations.This conference would address the challenges in the continual evolution of industry standards, technologies, and regulations. Leading experts from the industry will discuss the strategies for both in-house manufacturing and outsourcing by presenting expert keynote presentations, live case studies and breakthrough panel discussions.Learn from 20+ industry-leading speakers who will be sharing their presentations on Challenges during the development of chemical processes of HPAPIs, Handling of highly potent products in a multi-product facility & Manufacturing Strategies for Highly Potent API's.Why Attend?Utilizing the best practices to ensure the safe and efficient production of highly potent medicinesTraining sessions on complex high potent compounds handling and containment issuesUnderstanding the updated regulatory guidelines in the HPAPI processImplementing response plans to react to an unplanned eventKnowing the outsourcing strategies to effectively build a reliable supply chainKey HighlightsProcess Development and Scale Up of HPAPI'sRisk Identification during Cleaning HPAPI'sCross-Contamination Prevention Case StudiesContainment and Handling StrategiesRegulatory LandscapeHazard Assessment ClassificationsAgenda DAY ONERegistration08:15 - 08:55Welcome note08:55 - 09:00Opening Remarks from the Chairman09:00 - 09:10Keynote Presentation: Manufacturing Strategies for Highly Potent API's09:10 - 09:45PROCESS DEVELOPMENT AND SCALE UP OF HPAPI'SChallenges during the development of chemical processes of HPAPIs - from lab to pilot plant scale09:45 - 10:20Morning Refreshments and Poster Presentation - One-to-One Networking Meetings10:20 - 11:10The development and manufacture of HPAPI drug products throughout the clinical phases11:10 - 11:45Solution Provider Presentation11:45 - 12:20ADCs requirements on high containment processing12:20 - 12:55Lunch and Poster Presentation - One-to-One Networking Meetings12:55 - 13:55Development and Manufacturing of Highly Potent APIs: from lab-scale to production scale13:55 - 14:30Making a successful outsourcing partnership14:30 - 15:05CONTAINMENT AND HANDLING STRATEGIESContainment Equipment and Factors Affecting Containment Performance15:05 - 15:40Afternoon Refreshments and Poster Presentation - One-to-One Networking Meetings15:40 - 16:30Handling of highly potent products in a multi-product facility16:30 - 17:05Verifying the containment performance of pharmaceutical manufacturing and primary packaging equipment17:05 - 17:40Closing Remarks from the Chairman17:40 - 17:45Drinks Reception & Networking17:45 - 19:00DAY TWO Registration08:15 - 08:5 Welcome note08:55 - 09:0 Opening Remarks from the Chairman09:00 - 09:1 Keynote Presentation: Cleaning Validation in API Small Molecule09:10 - 09:4 IDENTIFICATION OF RISKS DURING CLEANING HPAPI'SUsing banding approaches sensibly and appropriate use of cleaning limits09:45 - 10:2 Morning Refreshments and Poster Presentation - One-to-One Networking Meetings10:20 - 11:1 Solution Provider Presentation11:10 - 11:4 Identification of high-risk products based on toxicological hazards for regulatory purposes11:45 - 12:2 Prioritizing HPAPI's with respect to risks12:20 - 13:0 Lunch and Poster Presentation - One-to-One Networking Meetings13:05 - 14:0 OCCUPATIONAL TOXICOLOGY AND INDUSTRIAL HYGIENEApplying occupational exposure limits on HPAPIs14:05 - 14:4 Closing remarks from the Chairman14:40 - 14:4For more information about this conference visit https://www.researchandmarkets.com/r/8k7qvrResearch and Markets also offers Custom Research services providing focused, comprehensive and tailored research.CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Story continuesReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoOil prices fall again, on track for biggest weekly drop in over 4 yearsReutersMost face masks won’t protect you from the coronavirusYahoo Finance'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoThese stocks have been crushed since the coronavirus began to take down the U.S. marketMarketWatchRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo FinancePersonal loans growth rate rises, impacts retailersYahoo Finance VideoBeyond Meat beats on Q4 earnings, founder says 'we would be crazy not to invest in growth right now'Yahoo Finance